ロード中...
Treatment-related adverse effects with TKIs in patients with advanced or radioiodine refractory differentiated thyroid carcinoma: a systematic review and meta-analysis
BACKGROUND: Tyrosine kinase inhibitors (TKIs) have been administered to advanced or radio-iodine refractory differentiated thyroid carcinoma (RR-DTC) patients for years. We performed a pooled analysis to explore the frequency of severe adverse effects in advanced or RR-DTC patients treated with sora...
保存先:
| 出版年: | Cancer Manag Res |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6388981/ https://ncbi.nlm.nih.gov/pubmed/30863162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S191499 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|